Jeffrey Stavenhagen
Chief Tech/Sci/R&D Officer at DIANTHUS THERAPEUTICS, INC.
Profile
Jeffrey Stavenhagen is currently the Chief Scientific Officer at Dianthus Therapeutics, Inc. He previously held the same position at Therini Bio, Inc. from 2019 to 2023.
He obtained a doctorate degree from The Trustees of Columbia University in The City of New York.
Jeffrey Stavenhagen active positions
| Companies | Position | Start |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/11/2023 |
Former positions of Jeffrey Stavenhagen
| Companies | Position | End |
|---|---|---|
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 30/11/2023 |
Training of Jeffrey Stavenhagen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Jeffrey Stavenhagen
